Cargando…
Noncoding RNAs in Extracellular Fluids as Cancer Biomarkers: The New Frontier of Liquid Biopsies
The last two decades of cancer research have been devoted in two directions: (1) understanding the mechanism of carcinogenesis for an effective treatment, and (2) improving cancer prevention and screening for early detection of the disease. This last aspect has been developed, especially for certain...
Autores principales: | Pardini, Barbara, Sabo, Alexandru Anton, Birolo, Giovanni, Calin, George Adrian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721601/ https://www.ncbi.nlm.nih.gov/pubmed/31416190 http://dx.doi.org/10.3390/cancers11081170 |
Ejemplares similares
-
Circular RNAs in body fluids as cancer biomarkers: the new frontier of liquid biopsies
por: Wang, Sumeng, et al.
Publicado: (2021) -
Emerging noncoding RNAs contained in extracellular vesicles: rising
stars as biomarkers in lung cancer liquid biopsy
por: Cammarata, Giuseppe, et al.
Publicado: (2022) -
Circulating noncoding RNAs: promising biomarkers in liquid biopsy for the diagnosis, prognosis, and therapy of NSCLC
por: Li, Yilin, et al.
Publicado: (2023) -
Extracellular Vesicles from Thyroid Carcinoma: The New Frontier of Liquid Biopsy
por: Rappa, Germana, et al.
Publicado: (2019) -
Large Extracellular Vesicles—A New Frontier of Liquid Biopsy in Oncology
por: Pezzicoli, Gaetano, et al.
Publicado: (2020)